[1] Park JC,Lee JH,Cheoi K,et al.Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor[J].Eur J Nucl Med Mol Imaging,2012,39(7): 1107-1116. [2] Gessner R,Tauber R. Intestinal cell adhesion molecules.Live intestine cadherin[J]. Ann NY Acad Sci,2000,915: l36-143. [3] Boo YJ,Park JM,Kim J,et al.L1 expression as a marker for poor prognosis,tumor progression,and short survival in patients with colorectal cancer[J].Ann Surg Oncol,2007,14(5): 1703-1711. [4] Wang J,Yu JC,Kang WM,et al. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer[J].Ann Surg Oncol,2012,19(5): 1529-1534. [5] Ito R,Oue N,Yoshida K,et al.Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer[J].Virchows Arch,2005,447(4): 717-722. [6] Xu Y,Zhang J,Liu QS,et al. Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo[J].World J Gastroenterol,2012,18(24): 3129-3137. [7] Dong W,Yu Q,Xu Y. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia[J].Dig Dis Sci,2007,52(2):536-542. [8] Chen XZ,Zhang WK,Yang K,et al. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population[J].Mol Biol Rep,2012,39(9): 9031-9039. [9] Tocchi A,Costa G,Lepre L,et al.The role of serum and gastric juice levels of carcinoembryonic antigen,CA19- 9and CA72-4 in patients with gastric cancer[J]. Cancer Res Clin Oncol,1998,124(8): 450-455. [10] Bouaita L,Sassi S,Hamdane MM,et al. Gastric adenocarcinoma producing alpha-fetoprotein[J].Tunis Med,2012,90 (2):189-191. [11] Liu F,Zhou J,Zhou P,et al. The ubiquitin ligase CHIP inactivates NF-κB signaling and impairs the ability of migration and invasion in gastric cancer cells[J]. Int J Oncol,2015,46(5): 2096-2106. [12] Chu D,Zhang Z,Li Y,et al. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer[J]. Int J Cancer,2011,129(4): 887-895. [13] Salvador J,Cano-Serral G,Rodriguez-Sanz M,et al.Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2 Positive Advanced Gastric Cancer Treated With Trastuzumab[J].J Clin Oncol,2013,31(35): 4445-4452.
2017, Vol. 34 
